Search research articles
Contact Us
Filters
Showing results (151-160 of 188) with videos related to
Page
of 19
Sort By:
Future Oncology (London, England)
|
March 12, 2021
Molecular and morphological changes induced by ivosidenib correlate with efficacy in mutant-<i>IDH1</i> cholangiocarcinoma
Elia Aguado-Fraile, Ania Tassinari, Yuko Ishii, et al.
The Oncologist
|
October 25, 2018
A Phase Ib, Open-Label Study of Dalantercept, an Activin Receptor-Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma
Ghassan K Abou-Alfa, Rebecca A Miksad, Mohamedtaki A Tejani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2013
Phase I safety, pharmacokinetic, and pharmacodynamic study of SAR245408 (XL147), an oral pan-class I PI3K inhibitor, in patients with advanced solid tumors
Geoffrey I Shapiro, Jordi Rodon, Cynthia Bedell, et al.
Musculoskeletal Surgery
|
June 14, 2021
Correction to: A proposed "Radiological Evaluation Score for Bone Tumors" (REST): An objective system for assessment of a radiograph in patients with suspected bone tumor
A A Salunke, K Nandy, K Puj, et al.
Musculoskeletal Surgery
|
May 13, 2021
A proposed "Radiological Evaluation Score for Bone Tumors" (REST): An objective system for assessment of a radiograph in patients with suspected bone tumor
A A Salunke, K Nandy, K Puj, et al.
Neurology
|
April 26, 2001
A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy
G M Fenichel, R C Griggs, J Kissel, et al.
Nature Communications
|
March 22, 2019
Kinetic control of tunable multi-state switching in ferroelectric thin films
R Xu, S Liu, S Saremi, et al.
The Western Journal of Emergency Medicine
|
November 5, 2025
Pharmacogenomic Drug-Gene Interactions in Geriatric Emergency Department Patients Who Sustained Falls: A Pilot Study
Richard D Shih, Gabriella Engstrom, Abhijit S Pandya, et al.
Neuro-Oncology
|
November 9, 2021
Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenib
Benjamin M Ellingson, Grace Hyun J Kim, Matt Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2013
Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors
Leena Gandhi, Rastislav Bahleda, Sara M Tolaney, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 188) with videos related to
Sort By:
Page
of 19
Future Oncology (London, England)
|
March 12, 2021
Molecular and morphological changes induced by ivosidenib correlate with efficacy in mutant-<i>IDH1</i> cholangiocarcinoma
Elia Aguado-Fraile, Ania Tassinari, Yuko Ishii, et al.
The Oncologist
|
October 25, 2018
A Phase Ib, Open-Label Study of Dalantercept, an Activin Receptor-Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma
Ghassan K Abou-Alfa, Rebecca A Miksad, Mohamedtaki A Tejani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2013
Phase I safety, pharmacokinetic, and pharmacodynamic study of SAR245408 (XL147), an oral pan-class I PI3K inhibitor, in patients with advanced solid tumors
Geoffrey I Shapiro, Jordi Rodon, Cynthia Bedell, et al.
Musculoskeletal Surgery
|
June 14, 2021
Correction to: A proposed "Radiological Evaluation Score for Bone Tumors" (REST): An objective system for assessment of a radiograph in patients with suspected bone tumor
A A Salunke, K Nandy, K Puj, et al.
Musculoskeletal Surgery
|
May 13, 2021
A proposed "Radiological Evaluation Score for Bone Tumors" (REST): An objective system for assessment of a radiograph in patients with suspected bone tumor
A A Salunke, K Nandy, K Puj, et al.
Neurology
|
April 26, 2001
A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy
G M Fenichel, R C Griggs, J Kissel, et al.
Nature Communications
|
March 22, 2019
Kinetic control of tunable multi-state switching in ferroelectric thin films
R Xu, S Liu, S Saremi, et al.
The Western Journal of Emergency Medicine
|
November 5, 2025
Pharmacogenomic Drug-Gene Interactions in Geriatric Emergency Department Patients Who Sustained Falls: A Pilot Study
Richard D Shih, Gabriella Engstrom, Abhijit S Pandya, et al.
Neuro-Oncology
|
November 9, 2021
Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenib
Benjamin M Ellingson, Grace Hyun J Kim, Matt Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2013
Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors
Leena Gandhi, Rastislav Bahleda, Sara M Tolaney, et al.
Page
of 19